InsidersTradesSigma
Discover the detailed record of transactions filed by Rouan Sarah Kathryn, Director. Officer active across 1 companies, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 2 reports have been published. The latest transaction was filed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Sarah Kathryn Rouan is a Board Member at Navidea Biopharmaceuticals, Inc. She contributes to the governance of the company by bringing her expertise to the board. Her role involves overseeing operations and ensuring compliance with regulations. With her experience, she plays a vital role in strategic decision-making.